GTCR buys back Cole-Parmer in $2 bln-plus deal, producing 3x return for Golden Gate

The management team of Cole-Parmer reached out to GTCR this summer to solicit interest in a potential transaction, only two years after the Chicago PE firm exited its investment in the company.

3 October 2019•4 mins read
laboratory equipment, life sciences, chemistry, research, medical
LinkedInXEmail
LinkedInXEmail

Related articles